ImmunoGen, Inc. ( IMGN) - Stock Earnings
Stock symbol IMGN is outdated, potentially delisted? Maybe it is available on other exchange?
IMGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -40.6 million USD | 49.9 million USD |
| 2023Q2 | -4.2 million USD | 83.2 million USD |
| 2023Q3 | 30.7 million USD | 113.4 million USD |
IMGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -222.9 million USD | 108.8 million USD |
| 2022 | -222.9 million USD | 108.8 million USD |
| 2023 | -73.5 million USD | 287.6 million USD |
IMGN
Price: $31.24
52 week price:
Earnings Per Share: -0.28 USD
P/E Ratio: -111.54
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.7 million
Ebitda: -9.9 millionMarket Capitalization: 8.7 billion